OLEMA PHARMACEUTICALS INC's ticker is OLMA and the CUSIP is 68062P106. A total of 58 filers reported holding OLEMA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $186 | -99.7% | 15 | -99.8% | 0.00% | – |
| Q2 2023 | $72,186 | +109.9% | 7,994 | -19.4% | 0.00% | – |
| Q1 2023 | $34,395 | +1046.5% | 9,912 | +728.8% | 0.00% | – |
| Q3 2022 | $3,000 | -57.1% | 1,196 | -28.0% | 0.00% | – |
| Q2 2022 | $7,000 | -79.4% | 1,662 | -79.2% | 0.00% | – |
| Q1 2022 | $34,000 | -55.8% | 7,979 | -3.5% | 0.00% | – |
| Q4 2021 | $77,000 | -7.2% | 8,268 | +174.2% | 0.00% | – |
| Q3 2021 | $83,000 | +9.2% | 3,015 | +10.9% | 0.00% | – |
| Q2 2021 | $76,000 | +94.9% | 2,718 | +129.0% | 0.00% | – |
| Q1 2021 | $39,000 | -88.3% | 1,187 | -82.8% | 0.00% | – |
| Q4 2020 | $332,000 | – | 6,912 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 3,743,875 | $15,238,000 | 2.80% |
| Fairmount Funds Management LLC | 2,669,300 | $10,864,000 | 2.49% |
| BVF INC/IL | 7,611,503 | $30,979,000 | 1.50% |
| Vivo Capital, LLC | 1,689,515 | $6,876,000 | 0.69% |
| Cormorant Asset Management, LP | 2,082,000 | $8,474,000 | 0.64% |
| Newtyn Management, LLC | 500,000 | $2,035,000 | 0.39% |
| Kynam Capital Management, LP | 249,229 | $1,014,000 | 0.26% |
| Monaco Asset Management SAM | 130,000 | $529,000 | 0.23% |
| TANG CAPITAL MANAGEMENT LLC | 318,926 | $1,298,000 | 0.20% |
| Artal Group S.A. | 260,500 | $1,060,000 | 0.06% |